Pharmacologic Models of Generalized Absence Seizures in Rodents

Models of Seizures and Epilepsy

Volumn , Issue , 2006, Pages 111-126

  Cortez, Miguel A ^a   Snead, O Carter ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882912524     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088554-1/50012-8     Document Type: Chapter

References (135)

1. Abo M., Suzuki M., Senoo A., Miyano S., Yamauchi H., Yonemoto K., Watanabe S., et al. Influence of isoflurane concentration and hypoxia on functional magnetic resonance imaging for the detection of bicuculline-induced neuronal activation. Neurosignals 2004, 13:144-149.
2. Avoli M. Electroencephalographic and pathophysiological features of rat parenteral penicillin epilepsy. Exp Neurol 1980, 69:373-382.
3. Avoli M., Gloor P., Kostopoulos G., Gotman J. An analysis of penicillin-induced generalized spike and wave discharges using simultaneous recordings of cortical and thalamic single neurons. J Neurophysiol 1993, 50:819-837.
4. Banerjee P.K., Snead O.C. Thalamic mediodorsal and intralaminar nuclear lesions disrupt the generation of experimentally induced generalized absence-like seizures in rats. Epilepsy Res 1994, 17:193-205.
5. B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB. J Pharmacol Exp Ther 1995, 273:1534-1543.
6. Banerjee P.K., Snead O.C. Neuroactive steroids exacerbate γ-hydroxybutyric acid-induced absence seizures in rats. Eur J Pharmacol 1998, 359:41-48.
7. Banerjee P.K., Hirsch E., Snead O.C. gamma;-Hydroxybutyric acid induced spike and wave discharges in rats: relation to high affinity [3H]-γ-hydroxybutyric acid binding sites in the thalamus and cortex. Neuroscience 1993, 56:11-21.
8. 3H]g-hydroxybutyric acid (GHB) binding in thalamic relay nuclei increase during absence seizures. Brain Res 1998, 813:343-350.
9. Banerjee P.K., Olsen R.W., Tillakaratne N.J., Brailowsky S., Tobin A.J., Snead O.C. Absence seizures decrease steroid modulation of t-[35S]butylbicyclophosphorothionate binding in thalamic relay nuclei. J Pharmacol Exp Ther 1998, 287:766-772.
10. Banerjee P.K., Tillakaratne N.J., Brailowsky S., Olsen R.W., Tobin A.J., Snead O.C. Alterations in GABAA receptor alpha 1 and alpha 4 subunit mRNA levels in thalamic relay nuclei following absence-like seizures in rats. Exp Neurol 1998, 154:213-223.
11. Bearden L.J., Snead O.C., Healy C.T., Pegram G.V. Antagonism of gamma hydroxybutyrate-induced frequency shifts in the cortical EEG of rats by dipropylacetate. Electroencephalogr Clin Neurophysiol 1980, 49:181-183.
12. Blumenfeld H. From molecules to networks: cortical/subcortical interactions in the pathophysiology of idiopathic generalized epilepsy. Epilepsia 2003, 44(Suppl 2):7-15.
13. Browning R.A., Nelson D.K. Modification of electroshock and pentylenetetrazol seizure patterns in rats after pericollicular transections. Exp Neurol 1986, 93:546-556.
14. Buzsaki G., Bickford R.G., Ponomareff G., Thal L.J., Mandel R., Gage F.H. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci 1988, 8:4007-4026.
15. Buzsaki G., Laszlovszky I., Lajtha A., Vadasz C. Spike-and-wave neocortical patterns in rats: Genetic and aminergic control. Neuroscience 1990, 38:323-333.
16. Castro P.A., Pleasure S.J., Baraban S.C. Hippocampal heterotopia with molecular and electrophysiological properties of neocortical neurons. Neuroscience 2002, 114:961-972.
17. Cenedella R.J. Concentration dependent effects of AY-9944 and U18-666A on sterol synthesis in brain. Variable sensitivities of metabolic steps. Biochem Pharmacol 1980, 29:2751.
18. Chan K.F.Y., Jia Z., Murphy P.A., Burnham W.M., Cortez M.A., Snead O.C. Learning and memory impairment in rats with chronic atypical absence seizures. Exp Neurol 2004, 190:327-335.
19. Coenen A.M., Van Luijtelaar E.L. The WAG/Rij rat model for absence epilepsy: age and sex factors. Epilepsy Res 1987, 1:297-301.
20. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489-501.
21. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
22. Cornford E.M., Nguyen E.V., Landaw E.M. Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am J Physiol 2000, 279:1346-1354.
23. Cortez M.A., McKerlie C., Snead O.C. A model of atypical absence seizures: EEG, pharmacology and developmental characterization. Neurology 2001, 56:341-349.
24. Cortez M.A., Cunnane S.C., Snead O.C. Brain sterols in the AY-9944 rat model of atypical absence seizures. Epilepsia 2002, 43:3-8.
25. Cortez M.A., Gibson M.K., Snead O.C. SSADH deficient mice: EEG, pharmacology and developmental characterization. Epilepsia 2004, 45(Suppl 7):41.
26. Cox G.A., Lutz C.M., Yang C.L., Biemesderfer D., Bronson R.T., Fu A., Aronson P.S., et al. Sodium/hydrogen exchanger gene defectin slow-wave epilepsy mutant mice. Cell 1997, 91:139-148.
27. Crunelli V., Leresche N. Childhood absence epilepsy: genes channels, neurons, and networks. Nat Rev Neurosci 2002, 3:371-382.
28. Depaulis A., Bourguignon J., Marescaux C., Vergnes M., Schmitt M., Micheletti G., Warter J.M. Effect of gamma-hydroxybutyrate and gamma-butyrolactone derivatives on spontaneous generalized non-convulsive seizures in the rat. Neuropharmacology 1988, 27:683-689.
29. Depaulis A., Vergnes M., Marescaux C., Lannes B., Warter J.M. Evidence that activation of GABA receptors in the substantia nigra suppresses spontaneous spike-and-wave discharges in the rat. Brain Res 1988, 448:20-29.
30. Depaulis A., Snead O.C., Marescaux C., Vergnes M. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 1989, 498:64-72.
31. Depaulis A., Liu Z., Vergnes M., Marescaux C., Micheletti G., Warter J.M. Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus. Epilepsy Res 1990, 5:192-198.
32. Dufour F., Koning E., Nehlig A. Basal levels of metabolic activity are elevated in Genetic Absence Epilepsy Rats from Strasbourg (GAERS): measurement of regional activity of cytochrome oxidase and lactate dehydrogenase by histochemistry. Exp Neurol 2003, 182:346-352.
33. Dvornik D., Hill P. Effects of long term administration of AY-9944, an inhibitor of 7-dehydrocholesterol delta 7-reductase on serum and tissue lipids in the rat. J Lipid Res 1968, 9:587-595.
34. el Hamdi G., Boutroy M.J., Nehlig A. Effects of pentylenete-trazol-induced seizures on dopamine and norepinephrine levels and on glucose utilization in various brain regions of the developing rat. Int J Dev Neurosci 1992, 10:301-311.
35. Erdogan F., Golgeli A., Arman F., Ersoy A.O. The effects of pentylenetetrazole-induced status epilepticus on behavior emotional memory, and learning in rats. Epilepsy Behav 2004, 5:388-393.
36. Fariello R.G. Action of inhibitory amino acids on acute epileptic foci: an electrographic study. Exp Neurol 1979, 66:55-63.
37. Fariello R.G., Golden G.T. The THIP induced model of bilateral synchronous spike and wave in rodents. Neuropharmacology 1987, 26:161-165.
38. Ferrer I., Pozas E., Marti M., Blanco R., Planas A.M. Methylazoxymethanol acetate-induced apoptosis in the external granule cell layer of the developing cerebellum of the rat is associated with strong c-Jun expression and formation of high molecular weight c-Jun complexes. J Neuropathol Exp Neurol 1997, 156:1-9.
39. Fisher R.S., Prince D.A. Spike-wave rhythms in cat cortex induced by parenteral penicillin. II. Cellular features. Electoencephalogr Clin Neurophysiol 1977, 42:625-639.
40. Gloor P. Electrophysiology of generalized epilepsy. Electrophysiology of Epilepsy 1984, 107-136. Academic Press, London. P.A. Schwartzkroin, H.V. Wheal (Eds.).
41. Gloor P., Testa G. Generalized penicillin epilepsy in the cat: effects of intracarotid and intravertebral pentylenetetrazol and amobarbital injections. Electroencephalogr Clin Neurophysiol 1974, 36:499-515.
42. Gloor P., Fariello R.G. Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci 1988, 11:63-68.
43. Godschalk M., Dzoljic M.R., Bonta I.L. Slow wave sleep and a state resembling absence epilepsy induced in the rat by gamma-hydroxybutyrate. Eur J Pharmacol 1977, 44:105-111.
44. Gofflot F., Gaoua W., Bourguignon L., Roux C., Ricard J.J. Expression of Sonic Hedgehog downstream genes is modified in rat embryos exposed in to a distal inhibitor of cholesterol biosynthesis. Dev Dyn 2001, 220:99-111.
45. Guberman A., Gloor P., Sherwin A.L. Response of generalized penicillin epilepsy in the cat to ethosuximide and diphenylhydantoin. Neurology 1975, 25:758-764.
46. Hosford D.A. Animal models of nonconvulsive status epilepticus. J Clin Neurophysiol 1999, 16:306-313.
47. Hu R.Q., Banerjee P.K., Snead O.C. Regulation of gamma-aminobutyric acid (GABA) release in cerebral cortex in the gamma-hydroxybutyric acid (GHB) model of absence seizures in rat. Neuropharmacology 2000, 39:427-439.
48. Hu R.Q., Cortez M.A., Man H.Y., Roder J., Jia Z., Wang Y.T., Snead O.C. Gamma-hydroxybutyric acid-induced absence seizures in GluR2 null mutant mice. Brain Res 2001, 897:27-35.
49. Hu R.Q., Cortez M.A., Man H.Y., Wang Y.T., Snead O.C. Alteration of GluR2 expressoin in the rat brain following absence seizures induced by gamma-hydroxybutyric acid. Epilepsy Res 2001, 44:41-51.
50. A proposed diagnostic schema for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803. International League Against Epilepsy Commission Report.
51. Issandou M., Guillard R., Boullay A.B., Linhart V., Lopez-Perez E. Up-regulation of low-density liporotein receptor in human hepatocytes is induced by sequestration of free cholesterol in the endosomal/lysosomal compartment. Biochem Pharmacol 2004, 67:2281-2289.
52. Kaplan B.J. The epileptic nature of rodent electrocortical polyspiking is still unproven. Exp Neurol 1985, 88:425-436.
53. Kelly P.A., McCulloch J. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilisation. J Neurochem 1982, 39:613-624.
54. 2+ channels. Neuron 2001, 31:35-45.
55. Kleinlogel H. Spontaneous EEG paroxysms in the rat: effects of psychotropic and alpha-adrenergic agents. Neuropsychobiology 1985, 13:206-213.
56. Krsek P., Mikulecka A., Druga R., Hlinak Z., Kubova H., Mares P. An animal model of nonconvulsive status epilepticus: a contribution to clinical controversies. Epilepsia 2001, 42:171-180.
57. Kupferberg H. Animal models used in the screening of antiepileptic drugs. Epilepsia 2001, 42(Suppl 4):7-12.
58. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342:314-319.
59. Librizzi L., DeGrazia U., Corci D., de Curtis M. Barbiturate washout in an isolated guinea-pig brain preparation. Neurosci Lett 2005, 380:66-69.
60. Löscher W. Animal models of intractable epilepsy. Prog Neurobiol 1997, 53:239-258.
61. Marescaux C., Micheletti G., Vergnes M., Depaulis A., Rumbach L., Warter J.M. A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazole-induced seizures. Epilepsia 1984, 25:326-331.
62. McCornick D.a., Bal T. Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci 1997, 20:185-215.
63. McQueen J.K., Woodbury D.M. Attempts to produce spike wave complexes in the electrocorticogram of the rat. Epilepsia 1975, 16:295-299.
64. McIntyre D.C., Poulter M.O., Gilby K. Kindling: some old and some new. Epilepsy Res 2002, 50:79-92.
65. Meldrum B. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs. Epilepsy Res 2002, 50:33-40.
66. Mirski M.A., Ferrendelli J.A. Anterior thalamic mediation of generalized pentylenetetrazol seizures. Brain Res 1986, 399:212-223.
67. Mirski M.A., McKeon A.C., Ferrendelli J.A. Anterior thalamus and substantia nigra: two distinct structures mediating experimental generalized seizures. Brain Res 1986, 397:377-380.
68. Mody I., Schwartzkroin P.A. Acute seizure models (intact animals). Epilepsy A Comprehensive Textbook 1997, vol 1:397-404. Lippincott-Raven, Philadelphia. J. Engel, T.A. Pedley (Eds.).
69. Morimoto K., Fahnestock M., Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 2004, 73:1-60.
70. Mueggler T., Baumann D., Rausch M., Rudin M. Bicuculline-induced brain activation in mice detected by functional magnetic resonance imaging. Magn Reson Med 2001, 46:292-298.
71. Nehlig A., Pereira de Vasconcelos A. The model of pentylenetetrazol-induced status epilepticus in the immature rat: short-and long-term effects. Epilepsy Res 1996, 26:93-103.
72. Nehlig A., Vergnes M., Marescaux C., Boyet S., Lannes B. Local cerebral glucose utilization in rats with petit mal-like seizures. Ann Neurol 1991, 29:72-77.
73. Nehlig A., Vergnes M., Marescaux C., Boyet S. Cerebral energy metabolism in rats with genetic absence epilepsy is not correlated with he pharmacologic increase or suppression of spike-wave discharges. Brain Res 1993, 618:1-8.
74. Nehlig A., Vergnes M., Boyet S., Marescaux C. Local cerebral glucose utilization in adult and immature GAERS. Epilepsy Res 1998, 32:206-212.
75. Nehlig A., Vergnes M., Boyet S., Marescaux C. Metabolic activity is increased in discrete brain regions before the occurrence of spike-and-wave discharges in weanling rats with genetic absence epilepsy. Brain Res Dev Brain Res 1998, 108:69-75.
76. Nersesyan H., Hyder F., Rothman D.L., Blumenfeld H. Dynamic fMRI and EEG recordings during spike-wave seizures and generalized tonic-clonic seizures in WAG/Rij rats. J Cereb Blood Flow Metab 2004, 24:589-599.
77. Nolan M., Bergazar M., Chu B., Cortez M.A., Snead O.C. The clinical and neurophysiological spectrum associated with atypical absence seizures. J Child Neurol 2004, 20(5):404-410.
78. Palacios J.M., Kuhar M.J., Rapoport S.I., London E.D. Effects of gamma-aminobutyric acid agonist and antagonist drugs on local cerebral glucose utilization. J Neurosci 1982, 2:853-860.
79. Penschuck S., Luscher B., Fritschy J.M., Crestani F. Activation of the GABA(A)-receptor delta-subunit gene promoter following pentylenetetrazole-induced seizures in transgenic mice. Brain Res Mol Brain Res 1997, 51:212-219.
80. Persad V., Cortez M.A., Snead O.C. A chronic model of atypical absence seizures: studies of developmental and gender sensitivity. Epilepsy Res 2002, 48:111-119.
81. Popa-Wagner A., Fischer B., Platt D., Schmoll H., Kessler C. Delayed and blunted induction of mRNA for tissue plasminogen activator in the brain of old rats following pentylenetetrazole-induced seizure activity. J Gerontol A Biol Sci Med Sci 2000, 55:242-248.
82. Quesney L.F. Pathophysiology of generlized photosensitive epilepsy in the cat. Epilepsia 1984, 25:61-69.
83. Racine R. Modification of seizure activity by electrical stimulation. I. After-discharge thresholds. Electroencephalogr Clin Neurophysiol 1972, 32:269-279.
84. Racine R. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
85. Riban V., Pereira de Vasconcelos A., Pham-Le B.T., Ferrandon A., Marescaux C., Nehlig A., Depaulis A. Modifications of local cerebral glucose utilization in thalamic structures following injection of a dopaminergic agonist in the nucleus accumbens-involvement in antiepileptic effects. Exp Neurol 2004, 188:452-460.
86. Rogawski M.A., Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004, 5:553-564.
87. Roth R.H., Giarman N.J. gamma;-butyrolactone and γ-hydroxybutyric acid. I. Distribution and metabolism. Biochem Pharmacol 1966, 15:1331-1348.
88. Roth R.H., Giarman N.J. Conversion in vivo of gamma-aminobutyric acid to gamma-hydroxybutyrate in the rat. Biochem Pharmacol 1969, 18:247-250.
89. Roth R.H., Delgado J.M.R., Giarman N.J. gamma;-Hydroxybutyric acid and γ-butyrolactone. The metabolically active form. Int J Neuropharmacol 1966, 5:421-428.
90. Roth R.H., Levy R., Giarman N.J. Dependence of rat serum lactonase upon calcium. Biochem Pharmacol 1967, 16:596-598.
91. Schickerova R., Mares P., Trojan S. Correlation between electrocorticographic and motor phenomena induced by pentylenetrazol during ontogenesis in rats. Exp Neurol 1984, 84:153-164.
92. Serbanescu I., Cortez M.A., McKerlie C., Snead O.C. Refractory atypical absence seizures in rat: a two hit model. Epilepsia Res 2004, 62(1):53-63.
93. Sillinpää M. Epidemiology of intractable epilepsy in children. Intractable Epilepsy 1995, 13-25. Wrightson Biomedical Publishing, Petersfield, UK. S.I. Johannessen, L. Gram, M. Sillinpää, T. Tomson (Eds.).
94. Sircar R., Veliskova J., Moshe S.L. Chronic neonatal phencyclidine treatment produces age-related changes in pentylenetetrazol-induced seizures. Brain Res Dev Brain Res 1994, 81:185-191.
95. Sitnikova E., van Luijtelaar G. Cortical control of generalized absence seizures: effect of lidocaine applied to the somatosensory cortex in WAG/Rij rats. Brain Res 2004, 1012:127-137.
96. Smith K.A., Bierkamper G.G. Paradoxical role of GABA in a chronic model of petit mal (absence)-like epilepsy in the rat. Eur J Pharmacol 1990, 176:45-55.
97. Snead O.C. Gammahydroxybutyrate in the monkey. I. Electroencephalographic, behavioral, and pharmacokinetic studies. Neurology 1978, 28:636-642.
98. Snead O.C. Gammahydroxybutyrate in the monkey. II. Effect of chronic oral anticonvulsant drugs. Neurology 1978, 28:643-648.
99. Snead O.C. Gammahydroxybutyrate in the monkey. III. Effect of intravenous anticonvulsant drugs. Neurology 1984, 28:1173-1178.
100. Snead O.C. Gamma-hydroxybutyric acid, gamma-aminobutyric acid and petit mal epilepsy. Neurotransmitters, Seizures, and Epilepsy 1984, vol II:37-38. Raven Press, New York. R.G. Fariellb, P.L. Morselli, K.G. Lloyd, L.F. Quesney, J. Engel (Eds.).
101. Snead O.C. Ontogeny of gamma-hydroxybutyric acid. II. Electroencephalographic effects. Brain Res 1984, 317:89-96.
102. Snead O.C. The γ-hydroxybutyrate model of generalized absence seizures: further characterization and comparison to other absence models. Epilepsia 1988, 29:361-368.
103. Snead O.C. The ontogeny of GABAergic enhancement of the gamma-hydroxybutyrate model of generalized absence seizures. Epilepsia 1990, 31:363-368.
104. Snead O.C. The γ-hydroxybutyrate model of absence seizures: correlation of regional brain levels of γ-hydroxybutyric acid and γ-butyrolactone with spike-wave discharges. Neuropharmacology 1991, 30:161-167.
105. Snead O.C. The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures. Brain Res 1994, 659:147-156.
106. Snead O.C. Basic mechanisms of generalized absence seizures. Ann Neurol 1995, 37:146-147.
107. B and γ-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav 1996, 53:73-79.
108. Snead O.C. gamma;-Hydroxybutyric acid and absence seizure activity. Gamma Hydroxybutyrate 2002, 132-141. Taylor and Francis, New York. G. Tunnicliff, C.D. Cash (Eds.).
109. A receptor function in the γ-hydroxybutyrate model of generalized absence seizures. Neuropharmacology 1993, 32:401-409.
110. Snead O.C., Cortez M.A. Ontogeny of spike and wave discharge (SWD) in the chronic model of atypical absence seizures. Neurology 1999, 52:A49.
111. Snead O.C., Yu R.K., Huttenlocher P.R. Gamma-hydroxybutyrate. Correlation of serum and cerebrospinal fluid levels with electroencephalographic and behavioral effects. Neurology 1976, 26:51-56.
112. Snead O.C., Bearden L.J., Pegram V. Effect of acute and chronic anticonvulsant administration on endogenous gamma-hydroxybutyrate in rat brain. Neuropharmacology 1980, 19:47-52.
113. Snead O.C., Depaulis A., Vergnes M., Marescaux C. Absence epilepsy: advances in experimental animal models. Adv Neurol 1999, 79:253-278.
114. Snead O.C., Banerjee P.K., Burnham M., Hampson D. Modulation of absence seizures by the GABA(A) receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4). J Neurosci 2000, 20:6218-6224.
115. Steriade M., Amzica F. Sleep oscillations developing into seizures in corticothalamic systems. Epilepsia 2003, 44(Suppl 12):9-20.
116. Steriade M., Llinas R.R. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 1988, 68:649-742.
117. Steriade M., Gloor P., Llinas R.R., Lopes da Silva F.H., Mesulam M.M. Basic mechanisms of cerebral rhythmic activities. Electroencephalogr Clin Neurophysiol 1990, 76:481-508.
118. Talley E.M., Solorzano G., Depaulis A., Perez-Reyes E., Bayliss D.A. Low-voltage-activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat. Brain Res Mol Brain Res 2000, 175:159-165.
119. Taylor-Courval D., Gloor P. Behavioral alterations associated with generalized spike and wave discharges in the EEG of the cat. Exp Neurol 1984, 83:167-186.
120. Tenney J.R., Duong T.Q., King J.A., Ferris C.F. FMRI of brain activation in a genetic rat model of absence seizures. Epilepsia 2004, 45:576-582.
121. Timofeev I., Grenier F., Steriade M. Contribution of intrinsic neuronal factors in the generation of cortically driven electrographic seizures. J Neurophysiol 2004, 92:1133-1143.
122. Tsakiridou E., Bertolini L., DeCurtis M., Avanzini G., Pape H.C. Selective increasein T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J Neurosci 1995, 153:3110-3117.
123. van de Bovenkamp-Janssen M.C., Scheenen W.J., Kuijpers-Kwant F.J., Kozicz T., Veening J.G., van Luijtellar E.L., McEnery M.W., et al. Differential expression of high voltage-activated Ca2+ channel types in the rostral reticular thalamic nucleus of the absence epileptic WAG/Rij rat. J Neurobiol 2004, 58:467-478.
124. Vanderwolf C.H. Neocortical and hippocampal activation in relation to behavior effects of atropine, eserine, phenothiazines, and amphetamine. J Comp Physiol Psychol 1975, 88:300-323.
125. Veliskova J., Velisek L., Moshe S.L. Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats. Epilepsia 1996, 37:718-722.
126. Vergnes M., Marescaux C., Micheletti G., Rumbach L., Warter J.M. Blockade of "antiabsence" activity of sodium valproate by THIP in rat model of genetic petit mal-like seizures. Comparison with ethosuximide. J Neural Transm 1985, 63:133-141.
127. Vergnes M., Marescaux C., Depaulis A., Micheletti G., Warter J.M. The spontaneous spike and wave discharges in Wistar Rats: a model of genetic generalized nonconvulsive epilepsy. Generalized Epilepsy: Neurobiological Approaches 1990, 238-253. Birkhauser, Boston. M. Avoli, P. Gloor, G. Kostopoulos, R. Naquet (Eds.).
128. White H.S. Animal models of epileptogenesis. Neurology 2002, 59(Suppl 5):S7-S14.
129. Williams D. A study of thalamic and cortical rhythms in petit mal. Brain 1953, 76:50-69.
130. Wong M., Wozniak D.F., Yamada K.A. An animal model of generalized nonconvulsive status epilepticus: immediate characteristics and long-term effects. Exp Neurol 2003, 183:87-99.
131. Wu J., Ellsworth K., Ellsworth M., Schroeder K.M., Smith K., Fisher R.S. Abnormal benzodiazepine and zinc modulation of GABAA receptors in an acquired absence epilepsy model. Brain Res 2004, 1013:230-240.
132. Yount G.L., Ponsalle P., White J.D. Pentylenetetrazole-induced seizures stimulate transcription of early and late response genes. Brain Res Mol Brain Res 1994, 21:219-224.
133. Zhang X., Ju G., Le Gal La Salle G. Fos expression in GHB-induced generalized absence epilepsy in the thalamus of the rat. Neuroreport 1991, 2:469-472.
134. d-aspartate receptor subunit levels in rats with pentylenetetrazole-induced seizures. Neurosci Lett 2004, 356:53-56.
135. Zifkin B.G. The Lennox-Gastaut syndrome. Comprehensive Epileptology 1990, 123-131. Raven Press, New York. M. Dam, L. Gram (Eds.).